One of the mysteries of Alzheimer dementia (AD) has been the normal function of the amyloid precursor protein (APP);  these specialized proteins are concentrated at the points where neurons connect within the brain. Even though the sticky amyloid plaques (which have been viewed as a hallmark sign of AD) result from APP, it seems unlikely that APP exists simply to cause AD. In a recent study, scientists from the U.S. and France show that APP binds to netrin-1, a protein that helps to guide nerves and their connections in the brain, as well as helping nerve cells to survive. When netrin-1 was given to mice that have a gene for AD, their symptoms were reversed, and the sticky amyloid was reduced.

These results suggest that the long-held belief that AD is caused by brain cell damage inflicted by the amyloid plaques may be wrong; instead, it is beginning to appear that the disease stems from an imbalance between the normal making and breaking of connections in the brain, with netrin-1 supporting the connections and the amyloid breaking the connections — both by binding to APP and activating normal cell functional programs.  One thing about novel molecular nanoresearch is that it always keeps things interesting. | LINK

Related Posts Within Doctor Pundit:

1. New Alzheimer Treatment Research Targets Spinal Fluid It has long been known the association between the existence...
2. Alzheimer Association Paints Dire Picture of Future Dementia Treatment Costs Did Barack Obama have this healthcare tidbit in mind when...
3. Tuesday Newswire: It’s All about Alzheimer Dementia We’ve always known the prevalence of dementia increases with age....
4. Research Trends Positively Influence Approach to Alzheimer Dementia Research into better treatments and possible cures of Alzheimer dementia...
5. Pharma Company’s Research Actions May Have Short Term Setback in Alzheimer Research Pharma company Eli Lilly recently scrapped further development of an...